Literature DB >> 2337209

Haemodynamic and neurohumoral effects of xenon anaesthesia. A comparison with nitrous oxide.

F Boomsma1, J Rupreht, A J Man in 't Veld, F H de Jong, M Dzoljic, B Lachmann.   

Abstract

Thirty-two patients were randomly allocated to be anaesthetised either with nitrous oxide or xenon. Those who received nitrous oxide required significantly more fentanyl peroperatively. Arterial blood pressure and heart rate were adequately controlled during surgery in both groups. Plasma noradrenaline and prolactin increased peroperatively in both groups, but plasma adrenaline and cortisol, which increased in the nitrous oxide group, did not change in the xenon group. Growth hormone was below control in those given xenon, but not in the nitrous oxide group, while dopamine remained unchanged in both groups. Postoperative plasma concentrations of noradrenaline, adrenaline, cortisol and prolactin (in both groups) and dopamine (in the nitrous oxide group) were elevated, and slowly returned to control. No differences were seen between the two gases in effects on plasma sodium and potassium. Xenon, because of its favourable haemodynamic, neurohumoral and antinociceptive properties, deserves a more prominent place in anaesthetic practice than it has so far occupied.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2337209     DOI: 10.1111/j.1365-2044.1990.tb14731.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  8 in total

1.  Xenon offers stable haemodynamics independent of induced hypothermia after hypoxia-ischaemia in newborn pigs.

Authors:  Elavazhagan Chakkarapani; Marianne Thoresen; Xun Liu; Lars Walloe; John Dingley
Journal:  Intensive Care Med       Date:  2011-12-13       Impact factor: 17.440

2.  Xenon-induced flow activation in patients with cerebral insult who undergo xenon-enhanced CT blood flow studies.

Authors:  P Horn; P Vajkoczy; C Thomé; E Muench; L Schilling; P Schmiedek
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

3.  Xenon washout during in-vitro extracorporeal circulation using different oxygenators.

Authors:  Uwe Schirmer; Helmut Reinelt; Matthias Erber; Michael Schmidt; Thomas Marx
Journal:  J Clin Monit Comput       Date:  2002 Apr-May       Impact factor: 2.502

Review 4.  Bench-to-bedside review: Molecular pharmacology and clinical use of inert gases in anesthesia and neuroprotection.

Authors:  Robert Dickinson; Nicholas P Franks
Journal:  Crit Care       Date:  2010-08-12       Impact factor: 9.097

Review 5.  Neuroprotective Properties of Xenon.

Authors:  Mervyn Maze; Timo Laitio
Journal:  Mol Neurobiol       Date:  2019-11-22       Impact factor: 5.590

6.  Pulmonary resistance in dogs: a comparison of xenon with nitrous oxide.

Authors:  P Zhang; A Ohara; T Mashimo; H Imanaka; A Uchiyama; I Yoshiya
Journal:  Can J Anaesth       Date:  1995-06       Impact factor: 5.063

7.  Safety and feasibility of xenon as an adjuvant to sevoflurane anaesthesia in children undergoing interventional or diagnostic cardiac catheterization: study protocol for a randomised controlled trial.

Authors:  Sarah Devroe; Jurgen Lemiere; Marc Van de Velde; Marc Gewillig; Derize Boshoff; Steffen Rex
Journal:  Trials       Date:  2015-03-04       Impact factor: 2.279

8.  Therapeutic antioxidant medical gas.

Authors:  Atsunori Nakao; Ryujiro Sugimoto; Timothy R Billiar; Kenneth R McCurry
Journal:  J Clin Biochem Nutr       Date:  2008-12-27       Impact factor: 3.114

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.